filmov
tv
New Jersey Alliance for Clinical and Translational Science (NJ ACTS)
![preview_player](https://i.ytimg.com/vi/q1V79DDA5TE/hqdefault.jpg)
Показать описание
At the conclusion of this activity, participants should be better able to:
1. Identify the value of a CTSA Hub
2. Define Precision Medicine and characterize the heterogeneity of disease states
3. Describe why OnCore Clinical Trial Management System interfacing with EPIC and Deep6AI Cohort Builder can improve clinical trial execution
1. Identify the value of a CTSA Hub
2. Define Precision Medicine and characterize the heterogeneity of disease states
3. Describe why OnCore Clinical Trial Management System interfacing with EPIC and Deep6AI Cohort Builder can improve clinical trial execution